Sunshine Biopharma Inc (SBFM)
0.84
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.854
+0.01
(+1.67%)
After-Hours: 20:00
Sunshine Biopharma Price to Book Value: 0.0394 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.0394 |
| May 02, 2024 | 0.0393 |
| May 01, 2024 | 0.0403 |
| April 30, 2024 | 0.041 |
| April 29, 2024 | 0.0403 |
| April 26, 2024 | 0.0446 |
| April 25, 2024 | 0.0379 |
| April 24, 2024 | 0.0436 |
| April 23, 2024 | 0.0567 |
| April 22, 2024 | 0.0675 |
| April 19, 2024 | 0.0828 |
| April 18, 2024 | 0.1557 |
| April 17, 2024 | 0.1782 |
| April 16, 2024 | 0.3189 |
| April 15, 2024 | 0.2865 |
| April 12, 2024 | 0.3756 |
| April 11, 2024 | 0.4085 |
| April 10, 2024 | 0.4601 |
| April 09, 2024 | 0.4479 |
| April 08, 2024 | 0.454 |
| April 05, 2024 | 0.4783 |
| April 04, 2024 | 0.4314 |
| April 03, 2024 | 0.5088 |
| April 02, 2024 | 0.3841 |
| April 01, 2024 | 0.4994 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.2837 |
| March 27, 2024 | 0.2673 |
| March 26, 2024 | 0.2678 |
| March 25, 2024 | 0.2701 |
| March 22, 2024 | 0.2767 |
| March 21, 2024 | 0.2814 |
| March 20, 2024 | 0.2626 |
| March 19, 2024 | 0.2579 |
| March 18, 2024 | 0.2509 |
| March 15, 2024 | 0.2814 |
| March 14, 2024 | 0.2345 |
| March 13, 2024 | 0.2378 |
| March 12, 2024 | 0.249 |
| March 11, 2024 | 0.2697 |
| March 08, 2024 | 0.2734 |
| March 07, 2024 | 0.2847 |
| March 06, 2024 | 0.3095 |
| March 05, 2024 | 0.3921 |
| March 04, 2024 | 0.2106 |
| March 01, 2024 | 0.1422 |
| February 29, 2024 | 0.1422 |
| February 28, 2024 | 0.1443 |
| February 27, 2024 | 0.1453 |
| February 26, 2024 | 0.1461 |
| February 23, 2024 | 0.1348 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0379
Minimum
Apr 25 2024
324.73
Maximum
Jan 03 2022
20.17
Average
0.5335
Median
Price to Book Value Benchmarks
| Lexaria Bioscience Corp | 6.185 |
| Acasti Pharma Inc | 0.4302 |
| Aurinia Pharmaceuticals Inc | 1.930 |
| Edesa Biotech Inc | 2.514 |
| Xenon Pharmaceuticals Inc | 3.558 |
Price to Book Value Related Metrics
| PS Ratio | 0.0084 |
| Price | 0.84 |
| Earnings Yield | -2.35K% |
| Market Cap | 0.8354M |